Clinical Trials Directory

Trials / Completed

CompletedNCT04048616

Impact of Protein and Alkali Supplementation on Skeletal Muscle in Older Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
141 (actual)
Sponsor
Tufts University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

The central hypothesis is that higher protein intake and a neutralizing alkaline salt supplement will improve muscle performance and mass, compared to their respective placebos, in older men and postmenopausal women.

Detailed description

With aging, skeletal muscle mass and performance decline leading to an increased risk of falls and physical disability. There is ongoing research on whether increasing dietary protein intake in older adults improves indices of muscle health and thus translates to a reduction in physical disability. A main concern is that high protein results in a large dietary acid load from the breakdown of protein to acidogenic byproducts, which could in turn promote muscle degradation particularly in older adults with age-related declines in renal excretion of acid. The scientific premise of this project is that the balance between the amount of protein in the diet (anabolic component) and the net acid load of the diet (catabolic component) in part determines whether the diet as a whole has a net anabolic or catabolic effect on muscle. Preliminary data have suggested that a daily alkaline salt supplement (potassium bicarbonate, KHCO3) lowered the dietary acid load and improved lower extremity muscle power in postmenopausal women. The investigator's central hypothesis is that higher protein intake and a neutralizing alkaline salt will improve muscle performance and mass, compared to their respective placebos, in older men and postmenopausal women. To test the hypothesis, the investigators conducted a randomized, double-blind, placebo-controlled, 2x2 factorial study in underactive men and women age 65 and older on baseline lower protein diets. Participants were assigned to one of four groups: either a whey protein supplement (to raise protein intake to 1.5 g/kg/d) with or without KHCO3 81 mmol/d or an isocaloric placebo supplement with or without KHCO3 81 mmol/d for 24 wks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTwhey protein isolateone 15-25 gm (based on body weight) protein packet three times a day with each meal
DIETARY_SUPPLEMENTpotassium bicarbonate (KHCO3)two 13.5 mmol capsules three times a day with each meal
OTHERmicrocrystalline celluloseidentical placebo capsule
OTHERmaltodextrin powderisocaloric placebo powder

Timeline

Start date
2021-07-01
Primary completion
2023-12-21
Completion
2023-12-21
First posted
2019-08-07
Last updated
2025-05-18
Results posted
2025-05-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04048616. Inclusion in this directory is not an endorsement.